Advertisement

Ads Placeholder
Loading...

Pluristem Therapeutics Inc.

PSTI•NASDAQ
Healthcare
Biotechnology
$1.00
$-0.03(-2.91%)
U.S. Market is Open • 15:57

Pluristem Therapeutics Inc. (PSTI) Stock Overview

Explore Pluristem Therapeutics Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap40.8M
P/E Ratio-8.95
EPS (TTM)$-1.46
ROE1.11%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

PSTI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Pluristem Therapeutics Inc. (PSTI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -8.95 and a market capitalization of 40.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
-5.66%
Year-to-Date (YTD) Change
N/A
1-Year Change
-39.76%
3-Year Change
-73.54%
5-Year Change
-92.54%
All-Time (Max) Change
-99.81%

Contact Information

https://www.pluristem.com
972747107171
Matam Advanced Technology Park, Building No. 5, Haifa, NaN, 3508409

Company Facts

1,530 Employees
IPO DateDec 10, 2007
CountryIL

Frequently Asked Questions